{"id":518781,"date":"2021-07-28T07:04:12","date_gmt":"2021-07-28T11:04:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/"},"modified":"2021-07-28T07:04:12","modified_gmt":"2021-07-28T11:04:12","slug":"bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/","title":{"rendered":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW HAVEN, Conn., July  28, 2021  (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on Tuesday, August 10, 2021 before the open of the U.S. financial markets. BioXcel\u2019s management team will also host a conference call and webcast at 8:30 AM EDT to discuss the Company\u2019s financial results and to provide a general business update.<\/p>\n<table style=\"border-collapse: collapse;width:550px;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong>Conference Call &amp; Webcast Details<br \/><\/strong><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:150px;width:150px;min-width:150px\">\n            <strong>Date\/Time:<br \/>Domestic:<\/strong><br \/>\n            <br \/>\n            <strong>International:<\/strong><br \/>\n            \n          <\/td>\n<td style=\"max-width:400px;width:400px;min-width:400px\">Tuesday, August 10, 2021 at 8:30 AM Eastern Time<br \/>877-407-2985<br \/>201-378-4915<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">The webcast and the accompanying materials will be accessible* under &#8220;Events&#8221; on the News &amp; Media page of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fb-VtPW9FehqKJwqikcrKpjP62YVw844wE7gbSW2aY2WMduRdLBNMT0unSTZ_ndIPK158JOqTSRQjJ-On8M4rMEHJGsiyqxuaMqQLguCGTdMP-DvHJL9Vzn1oRUW7lx4\" rel=\"nofollow noopener\" target=\"_blank\">www.bioxceltherapeutics.com<\/a>.<\/p>\n<table style=\"border-collapse: collapse;width:550px;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\">\n            <strong>Replay<\/p>\n<p><\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:150px;width:150px;min-width:150px\">\n            <strong>Domestic:<br \/>International:\u00a0<\/strong><br \/>\n            <br \/>\n            <strong>Conference ID:<\/strong><br \/>\n            \n          <\/td>\n<td style=\"max-width:400px;width:400px;min-width:400px\">877-660-6853<br \/>201-612-7415<br \/>13721977<\/td>\n<\/tr>\n<tr>\n<td>\u00a0<\/td>\n<td>\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>*Replay available through at least August 24, 2021.<\/p>\n<p>\n        <strong>BioXcel Therapeutics, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcel&#8217;s drug re-innovation approach leverages existing approved drugs and\/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcel&#8217;s two most advanced clinical development programs are BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms, and BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment na\u00efve to checkpoint inhibitors. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fb-VtPW9FehqKJwqikcrKpjP62YVw844wE7gbSW2aY1VSKKwIJjoXjjudzlCCuv9ze-aiBoK3ZB5LqmeCvkz0LEQeBGY2QuXa3NOTPEN1uNmk2aEhfcjaGCFDt4ki4ay\" rel=\"nofollow noopener\" target=\"_blank\">www.bioxceltherapeutics.com<\/a>.<\/p>\n<p>Source: BioXcel Therapeutics, Inc.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/7c3b1a6e-c3b7-4707-b64d-e52bc5238c5b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Contact Information:\r\n\r\nMary Coleman\r\nVice President, Investor Relations\r\nBioXcel Therapeutics, Inc.\r\nmcoleman@bioxceltherapeutics.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on Tuesday, August 10, 2021 before the open of the U.S. financial markets. BioXcel\u2019s management team will also host a conference call and webcast at 8:30 AM EDT to discuss the Company\u2019s financial results and to provide a general business update. Conference Call &amp; Webcast Details Date\/Time:Domestic: International: Tuesday, August 10, 2021 at 8:30 AM Eastern Time877-407-2985201-378-4915 \u00a0 \u00a0 The webcast and the accompanying materials will be accessible* under &#8220;Events&#8221; on the News &amp; Media &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-518781","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on Tuesday, August 10, 2021 before the open of the U.S. financial markets. BioXcel\u2019s management team will also host a conference call and webcast at 8:30 AM EDT to discuss the Company\u2019s financial results and to provide a general business update. Conference Call &amp; Webcast Details Date\/Time:Domestic: International: Tuesday, August 10, 2021 at 8:30 AM Eastern Time877-407-2985201-378-4915 \u00a0 \u00a0 The webcast and the accompanying materials will be accessible* under &#8220;Events&#8221; on the News &amp; Media &hellip; Continue reading &quot;BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-28T11:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021\",\"datePublished\":\"2021-07-28T11:04:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/\",\"name\":\"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\",\"datePublished\":\"2021-07-28T11:04:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/","og_locale":"en_US","og_type":"article","og_title":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk","og_description":"NEW HAVEN, Conn., July 28, 2021 (GLOBE NEWSWIRE) &#8212; BioXcel Therapeutics, Inc. (\u201cBioXcel\u201d or the \u201cCompany\u201d) (NASDAQ: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on Tuesday, August 10, 2021 before the open of the U.S. financial markets. BioXcel\u2019s management team will also host a conference call and webcast at 8:30 AM EDT to discuss the Company\u2019s financial results and to provide a general business update. Conference Call &amp; Webcast Details Date\/Time:Domestic: International: Tuesday, August 10, 2021 at 8:30 AM Eastern Time877-407-2985201-378-4915 \u00a0 \u00a0 The webcast and the accompanying materials will be accessible* under &#8220;Events&#8221; on the News &amp; Media &hellip; Continue reading \"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-28T11:04:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021","datePublished":"2021-07-28T11:04:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/","name":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=","datePublished":"2021-07-28T11:04:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Nzg1NCM0MzE3OTMxIzIxOTI5NTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bioxcel-therapeutics-to-report-second-quarter-2021-financial-results-on-august-10-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioXcel Therapeutics to Report Second Quarter 2021 Financial Results on August 10, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=518781"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/518781\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=518781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=518781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=518781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}